NMD Pharma A/S is a biopharmaceutical company focused on developing novel therapeutics for neuromuscular diseases. Our proprietary technology platform enables the discovery of small molecule drugs that target the dysregulation of ion channels in muscle cells. We are dedicated to advancing innovative treatments for patients with debilitating muscle disorders.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

9 Patents

#15 in Aarhus

#298 in Denmark

Aarhus, Denmark

Nmd Pharma A/s

Forward Citations = 10

25 inventors:

Lars J S Knutsen (6 out of 6 patents)

Thomas Holm Pedersen (5 out of 7 patents)

Nicholas Kelly (5 out of 5 patents)

4. Claus Elsborg Olesen (4 out of 4 patents)

5. Marc A Labelle (4 out of 12 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Nmd Pharma A/s. Retrieved from https://idiyas.com/company/nmd-pharma-a-s

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

8 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]